Literature DB >> 730383

Interferon production in glia and glioma cell lines.

I Larsson, L E Landström, E Larner, E Lundgren, H Miörner, L Strannegård.   

Abstract

Interferon (IF) was produced in glia and glioma cell lines in titers comparable to those produced by human fibroblasts. It was inducible by both Sendai virus and polyriboinosinic:polyribocytidylic acid. "Superinduction" resulted in up to 500-fold-higher titers of IF. The IF appeared to be of the fibroblast type, as revealed by experiments using heat treatment, assay of antiviral activity in heterologous cell lines, and neutralization with specific antisera. Since large amounts of IF may easily be produced with glioma cell lines, such cells may be suitable for mass production of IF.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 730383      PMCID： PMC422229          DOI： 10.1128/iai.22.3.786-789.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  18 in total

1.  Production of human lymphoblastoid interferon.

Authors:  H Strander; K E Mogensen; K Cantell
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

Review 2.  Classification and biological nature of established human hematopoietic cell lines.

Authors:  K Nilsson; J Pontén
Journal:  Int J Cancer       Date:  1975-02-15       Impact factor: 7.396

3.  Human interferon: mass production in a newly established cell line, MG-63.

Authors:  A Billiau; V G Edy; H Heremans; J Van Damme; J Desmyter; J A Georgiades; P De Somer
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

4.  Is interferon tissue specific?- Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines.

Authors:  S Einhorn; H Strander
Journal:  J Gen Virol       Date:  1977-06       Impact factor: 3.891

5.  Pronounced antiviral activity of human interferon on bovine and porcine cells.

Authors:  I Gresser; M T Bandu; D Brouty-boye; M Tovey
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

6.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

7.  Interferon and interferon inducers in the treatment of malignancies.

Authors:  H B Levy
Journal:  Arch Intern Med       Date:  1970-07

8.  Aging in vitro and large-scale interferon production by 15 new strains of human diploid fibroblasts.

Authors:  J S Horoszewicz; S S Leong; M Ito; L Di Berardino; W A Carter
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Particles with RNA of high molecular weight and RNA-directed DNA polymerase in human brain tumors.

Authors:  W Cuatico; J R Cho; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

10.  A mechanism for the induction and regulation of human fibroblastoid interferon genetic expression.

Authors:  Y H Tan; W Berthold
Journal:  J Gen Virol       Date:  1977-03       Impact factor: 3.891
View more
  16 in total

1.  Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.

Authors:  T Aoki; K Tashiro; S Miyatake; T Kinashi; T Nakano; Y Oda; H Kikuchi; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 2.  Recent advances in immunobiology of brain tumors.

Authors:  M Tada; N de Tribolet
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

3.  IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.

Authors:  A Natsume; K Tsujimura; M Mizuno; T Takahashi; J Yoshida
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

4.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

5.  Cytokine gene expression on glioma cell lines and specimens.

Authors:  R Yamanaka; R Tanaka; T Saitoh; S Okoshi
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8.

Authors:  R Yamanaka; R Tanaka; S Yoshida; T Saitoh; K Fujita
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 7.  Neuroendocrine regulation of thyrotropin-releasing hormone (TRH) in the tuberoinfundibular system.

Authors:  R Toni; R M Lechan
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

8.  Immunological studies in patients with central nervous system tumors.

Authors:  L Palma; V Moschese; E Galli; C Barbieri; V R Lombardi; P Rossi
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

9.  Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells.

Authors:  G M Lauro; N Di Lorenzo; M Grossi; A Maleci; B Guidetti
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Sialyltransferase-1 in a human malignant glioma cell line. Kinetic characteristics and effect of human interferon-beta.

Authors:  A J Yates; J F Collins; P J Elder; R E Stephens
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.